Search

everythinglearnresearchcommunity

for

Search:↓

The document suggests doctors should watch for bone marrow suppression and severe hair loss in patients treated with Azathioprine.

Tofacitinib helped regrow hair in a woman with alopecia areata.

IGFBP-rP1 could be a new treatment for a common type of hair loss.

The new aptamer TAGX-0003 shows promise as an effective treatment for hair loss disorder alopecia areata.

Early diagnosis of frontal fibrosing alopecia is crucial to prevent permanent hair loss.

BAF200 is essential for proper heart and coronary artery formation.

GFC injections significantly improved hair growth and quality with minimal side effects.

Fgf9 helps create new hair follicles after injury through skin T cells.

CS12192 effectively treats alopecia areata with better safety than current options.

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

Promising cancer treatments were found, but the manufacturer closed.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Keratinocytes can reduce the survival of certain melanoma cells, suggesting new therapy paths.

Follistatin helps hair growth and cycling, while activin prevents it.

Blocking TGFβ can help treat fibrotic skin conditions by promoting fat cell formation.

Editing the FGF5 gene in sheep increases wool length, confirming its role in hair growth.

Expanding CD4+ Tregs can stop hair loss in alopecia areata.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

A new vaccine using a porous scaffold boosts immunity and protects against the flu better than traditional methods.

Mogamulizumab can cause hair loss and skin rashes.

BMS-470539 reduces skin fibrosis and inflammation.

GABEB is a less severe skin condition caused by a gene mutation affecting collagen, leading to blisters and other symptoms.

FGF18 helps keep hair in its resting phase, affecting hair growth cycles.

FOL-005, a new substance, was found to reduce hair growth without toxicity when injected into skin, suggesting it could be used to treat excessive hair growth.

Keloid skin disorder involves abnormal fibroblast activation and immune response, linked to a group of genes including FGF11.

Antiandrogenic drugs could be a good treatment option for frontal fibrosing alopecia.

Platelet-released growth factors can reduce inflammation in joint disease.

γδTregs may help treat autoimmune diseases like alopecia areata by promoting hair regrowth and reducing immune attacks.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.